Why Novo Nordisk Is A Strong Buy Despite Market Concerns
Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...
Hotdogs and motorways: The ripples created by Denmark's Ozempic and Wegovy boom
American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...
Why the market has missed a trick for this weight loss drug
Northcape Capital’s Wendy Herringer isn’t deterred by the 40 per cent crash in Novo Nordisk and is all in on a waste disposal ...
Ozempic really could blind you - it damages veins in the eye, major study finds
American doctors, who tracked over 37 million people, said the injections put users at higher risk of nonarteritic ischemic ...
Giftify, Inc. Announces Smart Savings Solution for Popular GLP-1 Diabetes and Weight Loss Medications
Demand GLP-1 Medications as Prescription Drug Market Grows SCHAUMBURG, IL, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Giftify, Inc. (NASDAQ:GIFT) (the "Company"), the owner and operator of CardCash.com and ...
‘We made 434pc on one stock – now we’re hunting for the next Ozempic’
However, in Polar Capital Global Healthcare trust, investors will find an extreme outlier – over the same period, the vehicle ...
berlingske.dk15h
Medicinalgiganter på vej til møde i Det Hvide Hus – emner af stor betydning for Novo Nordisk er på bordet
Den amerikanske medicinalindustri skal mødes med præsident Donald Trump i Det Hvide Hus. Industrien vil forsøge at få Trump til at lempe prispresset på dyr medicin som Wegovy og Ozempic. Spørgsmålet ...
Hims & Hers Health: The Ultimate Pick For The Next Decade
Hims & Hers Health, Inc. is a dramatically undervalued company if your holding period can be measured in decades. Read more ...
Why Walmart's warning may have more to do with weight-loss drugs than tariffs
The weakness was also weighing on shares of some of Walmart's rivals, as Costco Wholesale Corp.'s stock (COST) fell 2.2% and Target Corp. shares (TGT) shed 1.1%, to underperform the S&P 500 index's ...
Eli Lilly wants to use its weight-loss drug windfall to target Alzheimer's, hearing loss, and ALS
The weight-loss drug boom has transformed Eli Lilly (LLY), the maker of Zepbound, into the largest healthcare company in the world. Now, the pharma giant wants to reinvest its success with weight-loss ...